QFW
BIIB icon

QTR Family Wealth’s Biogen BIIB Stock Holding History

QTR Family Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$441K Buy
2,041
+51
+3% +$9.76K 0.15% 144
2026
Q1 		$356K Buy
1,990
+138
+7% +$25.4K 0.15% 162
2025
Q4 		$350K Buy
1,852
+92
+5% +$15K 0.15% 153
2025
Q3 		$247K Buy
+1,760
New +$238K 0.12% 201

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QTR Family Wealth's BIIB Position: Q2 2026 in Review

QTR Family Wealth increased its Biogen (BIIB) stake by 2.6% in Q2 2026, buying an estimated $9.76K and bringing the position to 2,041 shares worth $441K. The position accounts for 0.15% of the portfolio, ranked #144.

QTR Family Wealth first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • QTR Family Wealth held 2,041 shares of Biogen worth $441K as of Q2 2026.
  • QTR Family Wealth bought 51 Biogen shares in Q2 2026, an estimated $9.76K.
  • Biogen made up 0.15% of QTR Family Wealth's portfolio in Q2 2026, its #144 holding.
  • QTR Family Wealth first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on QTR Family Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.